Hidradenitis Suppurativa: An Update
Advances in Dermatology · 2007
DOI: 10.1016/j.yadr.2007.07.001 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advances in Dermatology, 2007. Verfasst von Robert A Lee und 2 weiteren Autor:innen. Beteiligte Einrichtung: Hospital of the University of Pennsylvania, Department of Dermatology, 3600 Spruce St., 2 Maloney, Philadelphia, PA 19104, USA. robert.lee@uphs.upenn…. Hauptthemen laut MEDLINE: Hidradenitis Suppurativa. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 104 Literaturangaben.
Abstract (Originalsprache)
HS is a chronic, debilitating inflammatory dermatosis that is often refractory to treatment. Many medical therapies have been tried and some show efficacy. The introduction of new immunosuppressive medications has revolutionized the treatment of psoriasis in dermatology. These therapies have the potential to powerfully abort the molecular signals driving inflammation in HS and perhaps even induce a remission. This may offer patients an alternative to radical excisional surgery. However, more studies are needed to evaluate the long-term effects of these medications, particularly in light of their association with an increased risk of malignancy and infection. Evaluation of treatment efficacy has been hindered by a lack of uniform standards to track treatment response. The classic clinical classification system has limitations but is a useful scheme to guide selection of treatments. Further laboratory studies may be warranted, depending on the clinical presentation (Box 3). While there are many approaches to treating HS, the authors offer an algorithm based on disease severity (Fig. 9). It is important to address many patient-oriented concerns, such as the pain, dampness, and smell associated with draining sinuses. Communication with the patient about expectations is important to direct treatment. Often a multidisciplinary approach involving dermatology, plastic surgery, gynecology, and urology may be necessary to diagnose and treat the disease. Both medical and surgical options should be explored before embarking on therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Hospital of the University of Pennsylvania, Department of Dermatology, 3600 Spruce St., 2 Maloney, Philadelphia, PA 19104, USA. robert.lee@uphs.upenn.edu
Zitieren
APA
Lee, R. A., Yoon, A., & Kist, J. (2007). Hidradenitis Suppurativa: An Update. Advances in Dermatology. https://doi.org/10.1016/j.yadr.2007.07.001
Vancouver
Lee RA, Yoon A, Kist J. Hidradenitis Suppurativa: An Update. Advances in Dermatology. 2007. doi:10.1016/j.yadr.2007.07.001
BibTeX
@article{Lee2007,
author = {Lee, Robert A and Yoon, Andrew and Kist, Joseph},
title = {Hidradenitis Suppurativa: An Update},
journal = {Advances in Dermatology},
year = {2007},
doi = {10.1016/j.yadr.2007.07.001}
}
EUVIMED